Literature DB >> 29255888

New Criteria Needed for Antisynthetase Syndrome.

Santos Castañeda1, Lorenzo Cavagna2, Miguel A González-Gay3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29255888     DOI： 10.1001/jamaneurol.2017.3872

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  7 in total

1.  Identification of Similarities Between Skin Lesions in Patients With Antisynthetase Syndrome and Skin Lesions in Patients With Dermatomyositis by Highly Multiplexed Imaging Mass Cytometry.

Authors:  Jay Patel; Adarsh Ravishankar; Spandana Maddukuri; Thomas Vazquez; Madison Grinnell; Victoria P Werth
Journal:  Arthritis Rheumatol       Date:  2022-03-11       Impact factor: 15.483

Review 2.  Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond.

Authors:  Angeles S Galindo-Feria; Antonella Notarnicola; Ingrid E Lundberg; Begum Horuluoglu
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

Review 3.  Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines [corrected].

Authors:  Alain Meyer; Carlo Alberto Scirè; Rosaria Talarico; Tobias Alexander; Zahir Amoura; Tadej Avcin; Simone Barsotti; Lorenzo Beretta; Jelena Blagojevic; Gerd Burmester; Ilaria Cavazzana; Patrick Cherrin; Laura Damian; Andrea Doria; João Eurico Fonseca; Federica Furini; Ilaria Galetti; Frederic Houssiau; Thomas Krieg; Larosa Maddalena; David Launay; Raquel Campanilho-Marques; Thierry Martin; Marco Matucci-Cerinic; Pia Moinzadeh; Carlomaurizio Montecucco; Maria Francisca Moraes-Fontes; Luc Mouthon; Rossella Neri; Sabrina Paolino; Yves Piette; Simona Rednic; Farah Tamirou; Angela Tincani; Natasa Toplak; Stefano Bombardieri; Eric Hachulla; Ulf Mueller-Ladner; Matthias Schneider; Vanessa Smith; Ana Vieira; Maurizio Cutolo; Marta Mosca; Lorenzo Cavagna
Journal:  RMD Open       Date:  2019-02-26

4.  The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives.

Authors:  Federica Furini; Aldo Carnevale; Gian Luca Casoni; Giulio Guerrini; Lorenzo Cavagna; Marcello Govoni; Carlo Alberto Sciré
Journal:  Front Med (Lausanne)       Date:  2019-10-31

Review 5.  Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.

Authors:  Caterina Vacchi; Andreina Manfredi; Giulia Cassone; Gian Luca Erre; Carlo Salvarani; Marco Sebastiani
Journal:  Drugs Context       Date:  2021-01-15

6.  Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.

Authors:  Shaney L Barratt; Havra H Adamali; Caroline Cotton; Ben Mulhearn; Hina Iftikhar; John David Pauling; Lisa Spencer; Huzaifa I Adamali; Harsha Gunawardena
Journal:  BMJ Open Respir Res       Date:  2021-01

7.  Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.

Authors:  Philipp Eller; Holger Flick; Gernot Schilcher; Florentine Moazedi-Fürst; Kathrin Eller; Emina Talakic; Josef Hermann; Yannick Allanore; Horst Olschewski
Journal:  BMC Pulm Med       Date:  2021-01-06       Impact factor: 3.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.